Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-04-17
2007-04-17
Tate, Christopher R. (Department: 1657)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
11119360
ABSTRACT:
Methods and systems for rapidly determining the level of platelet inhibition in whole blood, due to aspirin usage, with a single use arachidonic based assay device that can be stored at room temperature is provided. A lyophilized assay reagent that contains arachidonic acid at sufficient concentration to maximally activate platelets is utilized. An antioxidant within the same lyophilized assay reagent reduces the oxidation rate of arachidonic acid but does not interfere with platelet function. An oxygen absorber within the single use assay device packaging creates an inert environment within a short period of time after package is sealed. The assay device can have a housing with a plurality of channels and a common blood sample introduction port coupled to each of a channel of the plurality of channels. The assay device can also include a lyophilized assay reagent that contains arachidonic acid at sufficient concentration to maximally activate platelets.
REFERENCES:
patent: 5763199 (1998-06-01), Coller
patent: 5922551 (1999-07-01), Durbin et al.
patent: 6531150 (2003-03-01), Sunohara et al.
patent: 6596191 (2003-07-01), Sakamoto et al.
Robert W. Colman, “Hemostasis and Thrombosis: Basic Principles and Clinical Practice”, Section 30, pp. 472-485, 1stEdition, Lippincott Williams & Wilkins, 1982.
A. Bye, et al., “Effect of a Single Oral Dose of Aspirin on the Platelet Aggregation Response to Arachidonic Acid” British Journal of Clinical Pharmacology, 7, pp. 283-286, 1979.
S. Moncada, et al., “Arahidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls”, The New England Journal of Medicine, vol. 300, No. 20, pp. 1142-1147, 1979.
C.M. Ingerman, et al., “Hereditary Abnormality of Platelet Aggregation Attributable to Nucleotide Storage Pool Deficiency”, Blood, vol. 52, No. 2, Aug. 1978.
David Stejskal, et al., “Application of Cationic Propyl Gallate as Inducer of Thrombocyte Aggregation for Evaluation Of Effectiveness of Antiaggregation Therapy”, Biomedical Papers, vol. 145, No. 2, pp. 69-74, 2001.
Barry S. Coller, et al., “A Murine Monoclonal Antibody that Completely Blocks the Binding of Fibrinogen to Platelets Produces a Thrombasthenic-like State in Normal Platelets and Binds to Glycoproteins IIb and/or IIIa”, The Journal of Clinical Investigation, vol. 72, pp. 325-338, Jul. 1983.
The Epic Investigators, “Use of a Monoclonal Antibody Directed Against the Platelet Clycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty” The New England Journal of Medicine, vol. 330, No. 4, pp. 956-961, Apr. 7, 1994.
Nigel S. Cook, et al., “Platelet Glycoprotein IIb/IIIa Antagonists”, Drugs of the Future, 19(2):135-159, 1994.
Pedro Cuatrecasas, et al., “Protein Purification by Affinity Chromatography”, The Journal of Biological Chemistry, vol. 245, No. 12, pp. 3059-3065, Jun. 25, 1970.
Durbin Dennis
McHugh Sean
Accumetrics, Inc.
Davis Paul
Heller Ehrman LLP
Tate Christopher R.
Wood Amanda P.
LandOfFree
Method and system for stabilization of arachidonic acid for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and system for stabilization of arachidonic acid for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and system for stabilization of arachidonic acid for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3752556